IMPLEXIS LTD

Registered Number
16297430
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2026

IMPLEXIS LTD

Company Information
for the period from 6 March 2025 to 31 March 2026


Directors	Youssef Wael Badreldin Mahmoud Abdalla, Dr
	Michael Thomas Cook
	David Robert Shorthouse


Registered Address	Implexis, Victoria House Bloomsbury Square
	7th Floor Incubator, Open Access Lab, Bench 8
	London
	WC1B 4DA


Registered Number	16297430 (England and Wales)

IMPLEXIS LTD

Balance Sheet as at
31 March 2026

		2026 £

Fixed Assets		2,294

Current Assets		67,615
Creditors amounts falling due within one year		(3,290)
Net current assets (liabilities)		64,325

Total assets less current liabilities		66,619

Creditors amounts falling due after one year		(250,000)
Net assets (liabilities)		(183,381)
Capital and reserves		(183,381)

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Average number of employees
The average number of persons employed by the company in the period was 2.
Directors advances, credits and guarantees
There were no advances, credits, or guarantees granted to the directors during the period.
Contingent Liabilities
There were no financial guarantees or commitments, either ongoing or entered into during the period.
Off Balance Sheet Arrangements
The company had no off-balance sheet arrangements at year-end or at any stage during the period.
Additional Disclosures
In preparing the annual accounts, the directors confirm that they believe the company can continue as a going concern for at least the next 12 months from the date of these accounts. The Directors have confirmed their intention to support the continued operation of the business.

The financial statements were approved and authorised for issue by the Board of Directors on 14 May 2026, and are signed on its behalf by:

Youssef Wael Badreldin Mahmoud Abdalla, Dr
Director
Registered Company No. 16297430